GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intra-Cellular Therapies Inc (STU:23I) » Definitions » 3-Year Revenue Growth Rate

Intra-Cellular Therapies (STU:23I) 3-Year Revenue Growth Rate : 147.00% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Intra-Cellular Therapies 3-Year Revenue Growth Rate?

Intra-Cellular Therapies's Revenue per Share for the three months ended in Mar. 2024 was €1.38.

During the past 12 months, Intra-Cellular Therapies's average Revenue per Share Growth Rate was 63.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 147.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 12 years, the highest 3-Year average Revenue per Share Growth Rate of Intra-Cellular Therapies was 300.00% per year. The lowest was -80.80% per year. And the median was 55.55% per year.


Competitive Comparison of Intra-Cellular Therapies's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Intra-Cellular Therapies's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intra-Cellular Therapies's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intra-Cellular Therapies's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Intra-Cellular Therapies's 3-Year Revenue Growth Rate falls into.



Intra-Cellular Therapies 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Intra-Cellular Therapies  (STU:23I) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Intra-Cellular Therapies 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Intra-Cellular Therapies's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Intra-Cellular Therapies (STU:23I) Business Description

Traded in Other Exchanges
Address
430 East 29th Street, New York, NY, USA, 10016
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Intra-Cellular Therapies (STU:23I) Headlines

No Headlines